Yan C - Search Results

1

Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, China.

Lu J, Hou J, Liu KY, Parmar S, De La Fuente A, Andersson B, Yan C, Zhou D, Tan D, Ritchie D, Wu D, Shpall E, Laport GG, Li J, Hu J, Zhang LS, Wang M, Malhotra P, Jiang Q, Qin Y, Wong R, Champlin R, Issaragrisil S, Iyer S, Mathews V, Wang Y, Hu Y, Xiao Z, Shao Z, Rosengarten R, Steuernagle J 4th, Xiao JH, Orlowski R, Chim CS. Lu J, et al. Among authors: yan c. Leuk Lymphoma. 2016 Jul;57(7):1534-8. doi: 10.3109/10428194.2015.1135434. Epub 2016 Feb 17. Leuk Lymphoma. 2016. PMID: 26887657

2

Diarrhea during the conditioning regimen is correlated with the occurrence of severe acute graft-versus-host disease through systemic release of inflammatory cytokines.

Liu D, Yan C, Xu L, Wang Y, Han W, Zhang X, Liu K, Huang X. Liu D, et al. Among authors: yan c. Biol Blood Marrow Transplant. 2010 Nov;16(11):1567-75. doi: 10.1016/j.bbmt.2010.05.001. Epub 2010 Sep 15. Biol Blood Marrow Transplant. 2010. PMID: 20546909 Free article. Clinical Trial.

3

[The efficacy and safety of second allogeneic hematopoietic stem cell transplantation for post-transplant hematologic malignancies relapse].

Chen YH, Xu LP, Chen H, Liu DH, Zhang XH, Han W, Wang FR, Wang JZ, Wang Y, Zhao T, Chen Y, Zhang YY, Yan CH, Sun YQ, Liu KY, Huang XJ. Chen YH, et al. Zhonghua Nei Ke Za Zhi. 2011 Jun;50(6):489-91. doi: 10.3760/cma.j.issn.0578-1426.2011.06.011. Zhonghua Nei Ke Za Zhi. 2011. PMID: 21781533 Chinese.

4

Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation.

Yan CH, Liu DH, Liu KY, Xu LP, Liu YR, Chen H, Han W, Wang Y, Qin YZ, Huang XJ. Yan CH, et al. Blood. 2012 Apr 5;119(14):3256-62. doi: 10.1182/blood-2011-09-380386. Epub 2012 Feb 14. Blood. 2012. PMID: 22337715 Free article.

5

Modified donor lymphocyte infusion-associated acute graft-versus-host disease after haploidentical T-cell-replete hematopoietic stem cell transplantation: incidence and risk factors.

Yan CH, Liu DH, Xu LP, Liu KY, Zhao T, Wang Y, Chen H, Chen YH, Han W, Huang XJ. Yan CH, et al. Clin Transplant. 2012 Nov-Dec;26(6):868-76. doi: 10.1111/j.1399-0012.2012.01618.x. Epub 2012 Mar 20. Clin Transplant. 2012. PMID: 22432715

6

Heart failure after allogeneic hematopoietic stem cell transplantation.

Mo XD, Xu LP, Liu DH, Zhang XH, Chen H, Chen YH, Han W, Wang Y, Wang FR, Wang JZ, Zhao T, Yan CH, Sun YQ, Liu KY, Huang XJ. Mo XD, et al. Int J Cardiol. 2013 Sep 10;167(6):2502-6. doi: 10.1016/j.ijcard.2012.06.021. Epub 2012 Jun 22. Int J Cardiol. 2013. PMID: 22727962

7

[Etiological analysis of fever in the first 24 hours following allogeneic peripheral stem cell transfusion].

Chen Y, Huang XJ, Wang FR, Yan CH, Wang Y, Zhang YY, Han W, Chen H, Liu DH, Liu KY, Xu LP. Chen Y, et al. Zhonghua Nei Ke Za Zhi. 2012 Mar;51(3):179-83. Zhonghua Nei Ke Za Zhi. 2012. PMID: 22781888 Chinese.

8

[The efficacy and safety of rituximab in treatment of Epstein-Barr virus disease post allogeneic hematopoietic stem-cell transplantation].

Xu LP, Liu DH, Liu KY, Zhang CL, Wang FR, Wang JZ, Wang Y, Chen H, Zhang YY, Yan CH, Han W, Chen YH, Zhao T, Zhang XH, Huang XJ. Xu LP, et al. Zhonghua Nei Ke Za Zhi. 2012 Dec;51(12):966-70. Zhonghua Nei Ke Za Zhi. 2012. PMID: 23327959 Chinese.

9

Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity.

Zhao XS, Yan CH, Liu DH, Xu LP, Liu YR, Liu KY, Qin YZ, Wang Y, Huang XJ. Zhao XS, et al. Ann Hematol. 2013 Aug;92(8):1111-9. doi: 10.1007/s00277-013-1733-1. Epub 2013 May 17. Ann Hematol. 2013. PMID: 23680867 Clinical Trial.

10

Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: superior outcomes compared with chemotherapy alone and an analysis of prognostic factors.

Yan CH, Wang JZ, Liu DH, Xu LP, Chen H, Liu KY, Huang XJ. Yan CH, et al. Eur J Haematol. 2013 Oct;91(4):304-14. doi: 10.1111/ejh.12168. Epub 2013 Aug 17. Eur J Haematol. 2013. PMID: 23837640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,448 results

Search Page

Filters